MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fvets.2026.1768078

Медицинская библиотека · Frontiers in veterinary science · 2026

OncoCan: a liquid biopsy assay for cell-free DNA quantification in canine plasma to support cancer prognosis.

Virginia Sánchez, Gal la Farreny, Elena Martinez-Merlo, Sara Trancon, Carlos Montañés José, Laura Enriquez, Arantxa Aguirrebeña, Agustín Arasanz Duque, Antonia Noce

СтатьяПеревод в очереди

Аннотация

Early cancer detection remains a major challenge in veterinary medicine. Cell-free DNA (cfDNA), released into the bloodstream through apoptosis, necrosis, or circulating tumor cells, can be quantified non-invasively via liquid biopsy and is already established in human oncology. In this study, we evaluated OncoCan, a targeted plasma cfDNA assay, by analyzing samples from 83 dogs with various neoplasms and 47 healthy controls to assess diagnostic and prognostic utility. Wilcoxon rank-sum testing revealed significantly higher cfDNA concentrations in neoplastic versus healthy samples (p = 4.45e-07). ROC curve analysis demonstrated high accuracy for lymphomas/leukemias (AUC = 0.95) and moderate accuracy for carcinomas (AUC = 0.75), sarcomas (AUC = 0.76), and melanomas (AUC = 0.69). Stratification by histological grade and clinical stage further supported cfDNA's predictive capability. Three practical thresholds were established: <50 pg/μL to distinguish healthy from neoplastic cases; ≥100 pg/μL as a "high positive" threshold indicating aggressive disease; and ≥300 pg/μL as a "very high positive" threshold strongly associated with systemic dissemination, high-grade histology, and poor survival. The <50 pg/μL cut-off showed robust diagnostic performance (AUC = 0.808, sensitivity = 82%, specificity = 73%), confirmed by survival analysis and hazard ratio modeling. These findings suggest that OncoCan provides a noninvasive, clinically applicable tool for cancer prognosis in dogs. Validation in larger cohorts is warranted to support its integration into routine veterinary oncology practice.

Для цитирования: Virginia Sánchez, Gal la Farreny, Elena Martinez-Merlo, Sara Trancon, Carlos Montañés José, Laura Enriquez, Arantxa Aguirrebeña, Agustín Arasanz Duque, Antonia Noce. OncoCan: a liquid biopsy assay for cell-free DNA quantification in canine plasma to support cancer prognosis.. Frontiers in veterinary science. 2026. DOI: 10.3389/fvets.2026.1768078.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.